Q3 net profit up 54%; Rs 75 interim dividend declared
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Revenue from operations for Q3 2026 rose 3% to Rs 491.7 crore, while net profit jumped 54% to Rs 116.7 crore. Profit before tax excluding exceptional items rose 22% to Rs 157.7 crore, helped by lower operating costs and a one-time reversal of provisions. The prior-year quarter included a Rs 27.3 crore separation cost. Nine-month revenue fell 1%. The board declared an interim dividend of Rs 75 per share, with 5 November 2026 as the record date.
Strong profit growth and the dividend may support sentiment, but nine-month revenue fell 1% and profit partly reflected a provision reversal.